^
1year
Universal 4SCAR7U Targeting CD7-positive Malignancies (clinicaltrials.gov)
P1, N=30, Recruiting, Shenzhen Geno-Immune Medical Institute
New P1 trial
|
CD7 (CD7 Molecule)
|
4SCAR7U